The prevalence of cardiovascular disease in my country continues to rise. There are 245 million hypertensive patients, and the awareness rate is only over half.

On the evening of the 25th, at the “Lujiazui Health Exchange” theme health forum, the guest speaker and director of the subspecialty of cardiology and cardiology, Zhongshan Hospital affiliated to Fudan University, Cheng Leilei, said: The prevalence of cardiovascular disease in my country is in a continuous rising stage. At present, there are about 245 million hypertensive patients. However, the awareness rate is 51.5%, the treatment rate is 46.1%, and the control rate is 16.9%. Only 1 out of 6 hypertensive patients is effectively controlled, and about 70% of stroke deaths and about 50% of stroke deaths. Myocardial infarction is closely related to hypertension.

The heart is one of the most important organs in humans. The human heart is like a small house. As the age increases, the house gradually ages. How to protect the heart, nourish the heart and strengthen the heart is an increasingly concerned issue in today’s society.

Cheng Leilei introduced: Malignant tumors have become one of the high-incidence diseases in my country. Various new anti-tumor drugs greatly prolong the survival time of tumor patients, but they also bring about side effects that cannot be ignored. As the life expectancy of cancer patients increases, the probability of complicating cardiovascular disease increases. How to formulate a targeted treatment plan for this population has become a new test for current cancer treatment.

Experts also reminded that major depression is a risk factor for heart disease. Among the patients with acute myocardial infarction in my country, the prevalence of depression was 21.7%. In recent years, the elites in the financial world have been affected by lifestyle and mental stress, and more and more health problems have occurred, the most common of which is cardiovascular disease, which requires more attention and care.

It is reported that the first multidisciplinary joint outpatient clinic of oncology cardiology in East China led by Cheng Leilei focuses on the detection and prevention of adverse cardiac reactions caused by chemotherapy, targeting and immunotherapy in cancer patients. . Not long ago, “Speak Your Heart 3” written by Cheng Leilei was published. She said: “I hope to translate and explain the obscure medical knowledge points in plain language and delicate brushstrokes in the most effective way, so that everyone can prevent cardiovascular diseases early, make timely judgments, and seek medical treatment scientifically.”

It is reported that “Lujiazui Health Exchange” is jointly sponsored by the Shanghai Municipal Health Promotion Committee Office and the China (Shanghai) Pilot Free Trade Zone Management Committee Lujiazui Administration, Shanghai Health Promotion Center and Shanghai De Entropy Business Consulting Co., Ltd. graciously undertakes.